Titan Pharmaceuticals Announces Journal of the American Medical Association Publication of Phase 3 Probuphine Data

Titan Pharmaceuticals Announces Journal of the American Medical Association Publication of Phase 3 Probuphine Data
Titan Pharmaceuticals, Inc. today announced that data from its previously completed and announced Phase 3 randomized, placebo-controlled clinical trial of Probuphine were published in the Journal of the American Medical Association . Â The article highlights data from the 163-patient trial, which showed that patients receiving Titan’s Probuphine implant had significantly less illicit opioid use …
Read more on PR Newswire via Yahoo! Finance